Article
Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterol
2026-02-06
Abstract excerpt
Hyperlipidemia, and high low-density lipoprotein cholesterol (LDL-c) in particular, is a risk factor for cardiovascular disease, including atherosclerosis, myocardial infarction, and stroke. Nearly 200 million people worldwide take HMG-CoA reductase inhibitors, commonly known as statins, to lower their LDL-c. If statins interfere with the genetic pathways that endogenously increase the risk for hyperlipidemia, gen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c9be2cb5-3d36-59fb-a4ff-0e2b8c91a76d
- DOI
- 10.64898/2026.02.04.703692
